 SEATTLE, April 21, 2021 PRNewswire -- CTI BioPharma Corp. NASDAQ: CTIC today announced that the Compensation Committee of its Board of Directors granted equity awards to two new employees as equity inducement awards outside of the Companys Amended and Restated 2017 Equity Incentive Plan but under the terms of the Amended and Restated 2017 Equity Incentive Plan and material to the employees acceptance of employment with the company. The equity awards were approved on April 21, 2021, in accordance with Nasdaq Listing Rule 5635c4. 